{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:53:23Z","timestamp":1767135203652,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd012122","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T00:00:00Z","timestamp":1461801600000}}],"reference-count":90,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012122.pub2","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T17:26:19Z","timestamp":1461950779000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Chlorpromazine versus reserpine for schizophrenia"],"prefix":"10.1002","volume":"2016","author":[{"given":"Selin","family":"Nur","sequence":"first","affiliation":[{"name":"Hochschule Ulm, University of Applied Sciences; Computer Science; Prittwitzstra\u00dfe 10 Ulm Germany 89075"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive E","family":"Adams","sequence":"additional","affiliation":[{"name":"The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health Innovation Park, Triumph Road, Nottingham UK NG7 2TU"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,4,28]]},"reference":[{"key":"10.1002\/14651858.CD012122.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1176\/ajp.113.1.16","article-title":"Thorazine and serpasil treatment of private neuropsychiatric patients","volume":"113","author":"Ayd","year":"1956","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012122.pub2-BIB0002|cit2","first-page":"209","article-title":"Study of the differential behavioral effects of reserpine, chlorpromazine, and a combination of these drugs in chronic schizophrenic patients","volume":"XVIII","author":"Barrett","year":"1957","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0003|cit3","first-page":"77","article-title":"Objective measurement of psychiatric changes produced by chlorpromazine and reserpine in chronic schizophrenia","volume":"1","author":"Gardner","year":"1955","journal-title":"Psychiatric Research Reports"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archneurpsyc.1955.02330170001001","article-title":"A comparison of chlorpromazine and reserpine in chronic psychosis","volume":"74","author":"Kovitz","year":"1955","journal-title":"American Medical Association Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0005|cit5","first-page":"143","article-title":"A comparison of chlorpromazine and reserpine in chronic psychosis","volume":"160","author":"Kovitz","year":"1956","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0006|cit6","first-page":"510","article-title":"A comparison of chlorpromazine and reserpine in the treatment of schizophrenia: a study of four hundred cases","volume":"75","author":"Kurland","year":"1956","journal-title":"American Medical Association Archives of Neurology and Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD012122.pub2-BIB0007|cit7","first-page":"698","article-title":"Drug treatment of schizophrenic patients. A comparative evaluation of chlorpromazine, chloprothixene, fluphenazine, reserpine, thioridazine and triflupromazine","volume":"23","author":"Lasky","year":"1962","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jnnp.19.3.232","article-title":"A controlled clinical study of chlorpromazine and reserpine in chronic schizophrenia","volume":"19","author":"Shepherd","year":"1956","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0009|cit9","volume-title":"Differential Treatment and Prognosis in Schizophrenia","author":"Wirt","year":"1959"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.1956.02960380027008","article-title":"Use of chlorpromazine and reserpine in the treatment of emotional disorders","volume":"160","author":"Zeller","year":"1956","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1176\/ajp.116.11.973","article-title":"Evaluation of tranquilizing drugs in the management of acute mental disturbance","volume":"117","author":"Abse","year":"1960","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/ajp.113.3.255","article-title":"Azacyclonol (Frenquel) in the treatment of chronic schizophrenics","volume":"113","author":"Barsa","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1176\/ajp.112.10.782","article-title":"Clinical investigation of chlorpromazine and reserpine in private psychiatric practice","volume":"112","author":"Bennett","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1176\/ajp.113.6.530","article-title":"The ataractic drugs: the present position of chlorpromazine, frenquel, pacatal, and reserpine in the psychiatric hospital","volume":"113","author":"Bowes","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1192\/bjp.104.434.201","article-title":"Combined chlorpromazine and reserpine in the treatment of chronic psychotics","volume":"104","author":"Foote","year":"1958","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0016|cit16","first-page":"65","article-title":"Psychiatric use of reserpine and chlorpromazine: results of double-blind studies","volume-title":"Psychopharmacology","author":"Hollister","year":"1956"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0017|cit17","first-page":"235","article-title":"EEG changes in chlorpromazine and reserpine treatment","volume":"106","author":"Holmberg","year":"1956","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0447.1956.tb09700.x","article-title":"A comparison between combined reserpine-chlorpromazine and chlorpromazine therapies in psychiatry","volume":"31","author":"Hormia","year":"1956","journal-title":"Acta Psychiatrica et Neurologica"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0020|cit19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/ajp.114.2.173-a","article-title":"Perphenazine - a drug modifying consciousness","volume":"114","author":"Mason-Browne","year":"1957","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0019|cit20","first-page":"300","article-title":"Effect of perphenazine (trilafon) on modification of crude consciousness","volume":"18","author":"Mason-Browne","year":"1957","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1176\/ajp.112.9.678","article-title":"Clinical evaluation of azacyclonol, chlorpromazine, and reserpine on a group of chronic psychotic patients","volume":"112","author":"Rinaldi","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00005053-195512000-00001","article-title":"A comparative study of the effect on anxiety of chlorpromazine, reserpine, phenobarbital, and a placebo","volume":"122","author":"Rosner","year":"1955","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1192\/bjp.103.430.200","article-title":"Combined treatment with chlorpromazine and reserpine: an attempt at quantitative assessments in chronic schizophrenic patients","volume":"103","author":"Schmidt","year":"1957","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0024|cit24","first-page":"452","article-title":"Comparison of chlorpromazine and reserpine in maintenance drug therapy","volume":"20","author":"Shawver","year":"1959","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archpsyc.1965.01720350078010","article-title":"Long-term follow-up study of schizophrenic patients","volume":"12","author":"Simon","year":"1965","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1176\/ajp.114.12.1077","article-title":"A controlled study of the short-term differential treatment of schizophrenia","volume":"114","author":"Simon","year":"1958","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012122.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.phymed.2015.01.002","article-title":"Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells","volume":"22","author":"Abdelfatah","year":"2015","journal-title":"Phytomedicine: International Journal of Phytotherapy and Phytopharmacology"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1741-7015-3-15","article-title":"Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials","volume":"3","author":"Adams","year":"2005","journal-title":"BMC Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012122.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000284.pub3","article-title":"Chlorpromazine versus placebo for schizophrenia","author":"Adams","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7066","key":"10.1002\/14651858.CD012122.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD012122.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1076\/jhin.12.2.207.15535","article-title":"The myth of reserpine-induced depression: role in the historical development of the monoamine hypothesis","volume":"12","author":"Baumeister","year":"2003","journal-title":"Journal of the History of the Neurosciences"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012122.pub2-BIB0033|cit33","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"issue":"10","key":"10.1002\/14651858.CD012122.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0035|cit35","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town Cape Town The Cochrane Collaboration 2000"},{"issue":"6","key":"10.1002\/14651858.CD012122.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012122.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0040|cit40","volume-title":"The Rohrschach Basic Foundations and Principles of Interpretation","volume":"1","author":"Exner","year":"2002"},{"issue":"4","key":"10.1002\/14651858.CD012122.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0009-9236(96)90193-9","article-title":"Reserpine: a tragic victim of myths, marketing, and fashionable prescribing","volume":"60","author":"Fraser","year":"1996","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0042|cit42","unstructured":"Fred the Oyster Chemical structure of reserpine https:\/\/commons.wikimedia.org\/wiki\/File:Reserpine.svg"},{"issue":"7","key":"10.1002\/14651858.CD012122.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012122.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/1097-4679(194710)3:4<375::AID-JCLP2270030410>3.0.CO;2-K","article-title":"The Rorschach test in clinical diagnosis","volume":"3","author":"Garfield","year":"1947","journal-title":"Journal of Clinical Psychology"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0045|cit45","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199755691.001.0001","volume-title":"Mayo Clinic Internal Medicine Board Review","author":"Ghosh","year":"2010"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.106.442.40","article-title":"A controlled trial of thiopropazate dihydrochloride (dartalan), chlorpromazine and occupational therapy in chronic schizophrenics","volume":"106","author":"Hamilton","year":"1960","journal-title":"Journal of Mental Science"},{"issue":"3","key":"10.1002\/14651858.CD012122.pub2-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003443.pub3","article-title":"Perphenazine for schizophrenia","author":"Hartung","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0049|cit49","unstructured":"Harvard Medical School Drug treatment of schizophrenia - the family health guide: drug treatment of schizophrenia http:\/\/www.health.harvard.edu\/family_health_guide\/drug-treatment-of-schizophrenia-the"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0050|cit50","unstructured":"Haynes RB Leenen FHH Conquering hypertension: an illustrated guide to understanding treatment and control of high blood pressure Conquering Hypertension: An Illustrated Guide to Understanding Treatment and Control of High Blood Pressure PMPH-USA 109"},{"issue":"3","key":"10.1002\/14651858.CD012122.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0920-9964(97)00024-8","article-title":"Clozapine-reserpine combination for refractory psychosis","volume":"25","author":"Healy","year":"1997","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0053|cit53","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org."},{"key":"10.1002\/14651858.CD012122.pub2-BIB0054|cit54","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"issue":"2","key":"10.1002\/14651858.CD012122.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/oxfordjournals.schbul.a007078","article-title":"The global costs of schizophrenia","volume":"30","author":"Knapp","year":"2004","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0056|cit56","unstructured":"Abel Lajtha Alterations of chemical equilibrium in the nervous system ISBN: 1461571758, 9781461571759 Springer Science & Business Media 353"},{"issue":"11","key":"10.1002\/14651858.CD012122.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.biopsych.2005.10.020","article-title":"Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology","volume":"59","author":"Leon","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD012122.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012122.pub2-BIB0060|cit60","first-page":"387","article-title":"Historical approach to reserpine discovery and its introduction in psychiatry","volume":"32","author":"Lopez-Munoz","year":"2004","journal-title":"Actas Espanolas de Psiquiatria"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0061|cit61","volume-title":"Handbook of Psychiatric Rating Scales (NIMH)","author":"Lyerly","year":"1973"},{"issue":"385","key":"10.1002\/14651858.CD012122.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/pgmj.33.385.544","article-title":"The complications of reserpine therapy","volume":"33","author":"Macarthur","year":"1957","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0064|cit64","unstructured":"Royal Pharmaceutical Society Martindale: the complete drug reference, chlorpromazine Martindale: The Complete Drug Reference https:\/\/www.medicinescomplete.com\/mc\/martindale\/current\/ms-7021-g.htm?q=chlorpromazine&t=search&ss=text&p=2#_hit The Pharmaceutical Press"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0065|cit65","unstructured":"National Institute of Mental Health Schizophrenia https:\/\/www.nimh.nih.gov\/health\/publications\/schizophrenia-booklet-12-2015\/index.shtml 2015"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"3","key":"10.1002\/14651858.CD012122.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"267\u201370","DOI":"10.1111\/j.2044-8341.1945.tb00762.x","article-title":"Porteus maze tests: applications in medical and allied fields","volume":"20","author":"Porteus","year":"1945","journal-title":"British Journal of Medical Psychology"},{"issue":"4","key":"10.1002\/14651858.CD012122.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/01.pra.0000281486.34817.8b","article-title":"Psychopharmacology, the evolution of antipsychotic drug therapy: reserpine, chlorpromazine, and haloperidol","volume":"13","author":"Preskorn","year":"2007","journal-title":"Journal of Psychiatric Practice"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0069|cit69","volume-title":"Psychodiagnostik","author":"Rohrschach H.","year":"1942"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0070|cit70","unstructured":"Bradley PB Lewis JJ The nervous system: central nervous system drugs Root WS Hofmann FG The Nervous System: Central Nervous System Drugs 1st Edition Elsevier [first publisher: Academic Press Inc.] 421 83"},{"issue":"14","key":"10.1002\/14651858.CD012122.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1001\/jama.287.14.1860-JMS0410-6-1","article-title":"Chlorpromazine and the psychopharmacologic revolution","volume":"287","author":"Rosenbloom","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD012122.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1371\/journal.pmed.0020141","article-title":"A systematic review of the prevalence of schizophrenia","volume":"2","author":"Saha","year":"2005","journal-title":"PLoS Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012122.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.euroneuro.2014.03.012","article-title":"Chlorpromazine versus every other antipsychotic for schizophrenia: a systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs","volume":"24","author":"Samara","year":"2014","journal-title":"European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology"},{"issue":"9593","key":"10.1002\/14651858.CD012122.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(07)61263-X","article-title":"Barriers to improvement of mental health services in low-income and middle-income countries","volume":"370","author":"Saraceno","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0075|cit75","first-page":"533","volume-title":"Textbook of Psychopharmacology","author":"Schatzberg","year":"2009"},{"issue":"3","key":"10.1002\/14651858.CD012122.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/h0056083","article-title":"Prognostic factors in schizophrenia","volume":"18","author":"Schofield","year":"1954","journal-title":"Journal of Consulting Psychology"},{"issue":"1","key":"10.1002\/14651858.CD012122.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0021-9258(18)54110-7","article-title":"Reserpine binding to a vesicular amine transporter expressed in Chinese hamster ovary fibroblasts","volume":"268","author":"Schuldiner","year":"1993","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"issue":"10","key":"10.1002\/14651858.CD012122.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009369.pub2","article-title":"Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0081|cit81","unstructured":"The NMR Spectroscopy Facility Reserpine http:\/\/www.southampton.ac.uk\/nmr\/capabilities\/solution-nmr\/example-spectra-solution\/reserpine.page"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"s7","DOI":"10.1136\/bmj.39034.609074.94","article-title":"Chlorpromazine: unlocking psychosis","volume":"334 Suppl 1","author":"Turner","year":"2007","journal-title":"BMJ (Clinical research ed.)"},{"issue":"5","key":"10.1002\/14651858.CD012122.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0084|cit84","unstructured":"Vinayaraj Rauwolfia serpentina https:\/\/commons.wikimedia.org\/wiki\/File:Rauwolfia_serpentina_(2)_-_%E0%B4%B8%E0%B4%B0%E0%B5%8D%E2%80%8D%E0%B4%AA%E0%B5%8D%E0%B4%AA%E0%B4%97%E0%B4%A8%E0%B5%8D%E0%B4%A7%E0%B4%BF.jpg"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1037\/10020-000","volume-title":"The Measurement of Adult Intelligence","author":"Wechsler","year":"1939"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0086|cit86","first-page":"33","article-title":"The World Health Report 2001, Mental Health: New Understanding New Hope","volume-title":"The World Health Report 2001, Mental Health: New Understanding New Hope","author":"WHO","year":"2001"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0087|cit87","unstructured":"WHO WHO Model List of Essential Medicines WHO Model List of Essential Medicines 18th Edition World Health Organization 33"},{"key":"10.1002\/14651858.CD012122.pub2-BIB0088|cit88","unstructured":"WHO Mental Health, Schizophrenia http:\/\/www.who.int\/mental_health\/management\/schizophrenia\/en\/ 2015"},{"issue":"3","key":"10.1002\/14651858.CD012122.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"395-430; discus","DOI":"10.1002\/(SICI)1097-4679(200003)56:3<395::AID-JCLP15>3.0.CO;2-O","article-title":"The Rorschach test in clinical diagnosis: a critical review, with a backward look at Garfield (1947)","volume":"56","author":"Wood","year":"2000","journal-title":"Journal of Clinical Psychology"},{"issue":"7","key":"10.1002\/14651858.CD012122.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012122.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T02:57:23Z","timestamp":1715050643000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012122.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,28]]},"references-count":90,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012122.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,28]]}}}